Biotech's movers for the week of August 24th and two catalysts to watch for the week ahead
Biotech cooled off from the excitement of Moderna and Merck's mRNA clinical trial success as a similar program failed in colorectal cancer. Capricor rose on a regulatory pivot and CLINUVEL's earnings disappointed.










.png)